The new antibodies, both those that constitute a cure and those that predict immunity, could not come at a more poignant time. ZEBOV, the strain tested in Kobinger�s study, can exhibit a case fatality rate as high as 90 percent. This month, the World Health Organization confirmed 25 deaths in the DR Congo from Ebola, which compounds the 15 deaths in Uganda.� - See more at: http://www.healthmap.org/site/diseasedaily/article/human-trials-ebola-vaccine-11812#sthash.gLipxuzI.dpuf